Amplyx Pharmaceuticals is Drug Discovery in United States that focus on continued convenient treatment business. Founded in 2006. They cover business area such as developer, antifungal agent, invasive fungal infection, both intravenous and oral formulation, treatment, discharge, patient, chemotherapy, compromise immune system, candida, aspergillus, rare mold.
2006
( 18 years old in 2024 )
Continued Convenient Treatment
-
12730 High Bluff Drive
Suite 160
San Diego, CA 92130
United States
Private
developerantifungal agentinvasive fungal infectionboth intravenous and oral formulationtreatmentdischargepatientchemotherapycompromise immune systemcandidaaspergillusrare mold
* We use standard office opening hours in near Amplyx Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Amplyx Pharmaceuticals is Drug Discovery business from United States that founded in 2006 (18 years old in 2024), Amplyx Pharmaceuticals business is focusing on Continued Convenient Treatment.
Amplyx Pharmaceuticals headquarter office and corporate office address is located in 12730 High Bluff Drive Suite 160 San Diego, CA 92130 United States.
Amplyx Pharmaceuticals was founded in United States.
In 2024, Amplyx Pharmaceuticals is currently focus on continued convenient treatment sector.
Above is snippet of Google Trends for "continued convenient treatment" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Amplyx Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
